Month 30 & 42 Extension Studies of CRD-004 Primary Study
NCT00492648
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Herpes Zoster
Interventions
PROCEDURE:
Blood sampling for assay of persistence of immunogenicity
Sponsor
GlaxoSmithKline